BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2364490)

  • 1. Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.
    Hall GT; Gardner TD; Potter EK
    Circ Res; 1990 Jul; 67(1):193-8. PubMed ID: 2364490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
    Warner MR; Levy MN
    Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
    Potter EK; McCloskey DI
    Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological separation of cardio-accelerator and vagal inhibitory capacities of sympathetic nerves.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Apr; 43(1):7-16. PubMed ID: 8315212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.
    Potter E
    Neurosci Lett; 1987 Dec; 83(1-2):101-6. PubMed ID: 3441289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus.
    Potter EK
    J Auton Nerv Syst; 1987 Nov; 21(1):87-90. PubMed ID: 3440821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization by neuropeptide Y of effects of sympathetic stimulation on cardiac vagal action in anaesthetised dogs.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Oct; 45(1):21-8. PubMed ID: 8227962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs.
    Revington ML; McCloskey DI
    J Physiol; 1990 Sep; 428():359-70. PubMed ID: 2231416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N; Yang T; Levy MN
    Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
    Ilebekk A; Björkman JA; Nordlander M
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
    Mahns DA; Lacroix JS; Potter EK
    J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.
    Moriarty M; Gibbins IL; Potter EK; McCloskey DI
    Neurosci Lett; 1992 May; 139(2):275-9. PubMed ID: 1376882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.
    Warner MR; Senanayake PD; Ferrario CM; Levy MN
    Circ Res; 1991 Aug; 69(2):455-65. PubMed ID: 1776971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat.
    Smith-White MA; Wallace D; Potter EK
    J Auton Nerv Syst; 1999 Feb; 75(2-3):171-5. PubMed ID: 10189119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats.
    Revington M; Potter EK; McCloskey DI
    J Physiol; 1990 Dec; 431():495-503. PubMed ID: 1712845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
    Owen MP
    J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal action on atrioventricular conduction and its inhibition by sympathetic stimulation and neuropeptide Y in anaesthetised dogs.
    Pirola FT; Potter EK
    J Auton Nerv Syst; 1990 Sep; 31(1):1-12. PubMed ID: 2262662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog.
    Gardner TD; Potter EK
    J Physiol; 1988 Nov; 405():115-22. PubMed ID: 3255790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.